Contract A207_PO-0450800

The University of Virginia awarded a purchase order (A207_PO-0450800) to Sigma-Aldrich Inc. on June 19, 2026, with a cumulative contract value of $341. The contract covers the procurement of pharmaceutical compounds for delivery to Dr. Surjya Dash at the University of Virginia. The two line items include Sitagliptin, a dipeptidyl peptidase-4 inhibitor used in diabetes management, priced at $98.10 per unit, and a glucagon-like peptide-1 receptor agonist (GLP-1R agonist), priced at $243.00 per unit. Both items are procured on a one-each basis.

This purchase order represents a straightforward procurement of research or clinical-grade pharmaceutical materials by the University of Virginia's contracting organization from Sigma-Aldrich Inc., a major supplier of life sciences products and chemicals. The contract execution in Virginia reflects the location of the contracting organization and the intended place of performance for delivery to the named recipient within the institution.